Susan M. Collins bought Valeant Pharmaceuticals International, Inc. (NYSE) (VRX)
Susan M. Collins (R-ME), a U.S. Senator, has disclosed 2 trades in Valeant Pharmaceuticals International, Inc. (NYSE) (VRX) since 2014, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Susan M. Collins bought $1,001 - $15,000 of Valeant Pharmaceuticals International, Inc. (NYSE) (VRX) on March 11, 2014. Since that trade, VRX is up +0.00% against the S&P 500 up +379.66%, an outperformance of -379.66%.
Across these filings, Susan M. Collins has been a balanced trader of VRX (a buy-to-sell ratio of 1.00). The most recent disclosed VRX transaction shown was dated May 7, 2014. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Susan M. Collins's VRX trades vs the price
VRX is up +0.00% since Susan M. Collins bought on March 11, 2014, versus +379.66% for the S&P 500.
Performance since this trade
All Susan M. Collins VRX trades
Susan M. Collins & VRX trading FAQ
Is it legal for Susan M. Collins to trade Valeant Pharmaceuticals International, Inc. (NYSE) (VRX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Valeant Pharmaceuticals International, Inc. (NYSE) (VRX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Susan M. Collins buy VRX?
Susan M. Collins disclosed a purchase of $1,001 - $15,000 of Valeant Pharmaceuticals International, Inc. (NYSE) (VRX) on March 11, 2014, according to public STOCK Act filings.
How has VRX performed since Susan M. Collins's trade?
Since Susan M. Collins bought VRX on March 11, 2014, the stock is up +0.00%, versus +379.66% for the S&P 500 over the same period, an outperformance of -379.66%.
How many times has Susan M. Collins traded VRX?
Susan M. Collins has disclosed 2 VRX trades since 2014 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional VRX trades?
Quantellect tracks every disclosed congressional trade in Valeant Pharmaceuticals International, Inc. (NYSE) (VRX) on the Valeant Pharmaceuticals International, Inc. (NYSE) congressional trading page, which aggregates filings across all members of Congress.
Susan M. Collins's VRX tradesAll congressional filings for Valeant Pharmaceuticals International, Inc. (NYSE)Susan M. Collins's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.